메뉴 건너뛰기




Volumn 5, Issue 3, 1996, Pages 237-245

Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: Report from the second Nordic workshop

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

EID: 0029764169     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.237     Document Type: Article
Times cited : (90)

References (5)
  • 1
    • 0029100164 scopus 로고
    • Report from a Nordic workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple patients
    • Johnsen, H.E., for the Nordic Myeloma Study Group Laboratories. Report from a Nordic workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple patients. J. Hematotherapy 4:21, 1995.
    • (1995) J. Hematotherapy , vol.4 , pp. 21
    • Johnsen, H.E.1
  • 2
    • 3042869445 scopus 로고    scopus 로고
    • Improved priming for mobilization and optimal timing for harvest of peripheral blood stem cells
    • In press
    • Knudsen, L.M., Gaarsdal E., Jensen L., et al. Improved priming for mobilization and optimal timing for harvest of peripheral blood stem cells. J Hematotherapy In press.
    • J Hematotherapy
    • Knudsen, L.M.1    Gaarsdal, E.2    Jensen, L.3
  • 3
    • 0026504705 scopus 로고
    • Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery from high-dose chemotherapy
    • Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery from high-dose chemotherapy. Lancet 3339:640, 1992.
    • (1992) Lancet , vol.3339 , pp. 640
    • Sheridan, W.P.1    Begley, C.G.2    Juttner, C.A.3
  • 4
    • 0026342057 scopus 로고
    • The use of GM-CSF and peripheral blood stem cells (PBSC) minimizes hematological toxicity following a myeloablative course of chemoradiotherapy
    • Gianni, A.M., Siena, S., Bregni, M., et al. The use of GM-CSF and peripheral blood stem cells (PBSC) minimizes hematological toxicity following a myeloablative course of chemoradiotherapy. Pathol. Biol. 39:956, 1992.
    • (1992) Pathol. Biol. , vol.39 , pp. 956
    • Gianni, A.M.1    Siena, S.2    Bregni, M.3
  • 5
    • 0025980856 scopus 로고
    • Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
    • Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
    • (1991) Blood , vol.77 , pp. 400
    • Siena, S.1    Bregni, M.2    Brando, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.